Determinants of Bladder Cancer Recurrence Study (The DETER Study) (NCT02400944) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
United States600 participantsStarted 2015-03
Plain-language summary
The purpose of this study is to learn how different lifestyle factors, such as cigarette smoking and body weight, change after a diagnosis of bladder cancer, and how they influence who gets a bladder cancer recurrence and who does not.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients ≥18 years old AND
* Histologically-confirmed non-muscle invasive bladder cancer (NMIBC)
Exclusion Criteria:
* Patients are ineligible for the study if they have/had:
* Histologically-confirmed NMIBC diagnosed \>36 months prior to enrollment
* Cystectomy prior to enrollment
* Any condition, which in the opinion of the primary MSK clinician or investigators precludes their ability to provide informed consent or comply with study procedures
* Non English-speaking
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study is focused on understanding what factors determine whether bladder cancer comes back — how might participating in it help my doctor better predict my own risk of recurrence?
2Since this study is observational and focused on recurrence patterns rather than testing a new treatment, does joining it involve any procedures or interventions beyond what I'd already be doing as part of my standard care?
3The study is no longer actively recruiting new participants — does that mean there's no longer any way for me to get involved, or are there similar studies I should ask about that are still enrolling?
4Since the primary outcome being measured is recurrence, will any data or findings from this study be shared back with me or my care team in a way that could directly inform decisions about my monitoring or treatment plan?
5Given that my bladder cancer has just been diagnosed, should I be prioritizing conversations about standard surveillance and treatment first, or is it worth exploring whether there are other recurrence-focused research opportunities available to me right now?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.